Literature DB >> 16338972

Regulation of epithelial tubule formation by Rho family GTPases.

Randi Eisen1, Shereaf Walid, Don R Ratcliffe, George K Ojakian.   

Abstract

Previous work has established that the integrin signal transduction pathway plays an important role in the regulation of epithelial tubule formation. Furthermore, it has been demonstrated that Rho-kinase, an effector of the Rho signaling pathway, is an important downstream modulator of collagen-mediated renal and mammary epithelial tubule morphogenesis. In the present study, MDCK cells that expressed mutant dominant-negative, constitutively active Rho family GTPases were used to provide further insight into Rho-GTPase signaling and the regulation of epithelial tubule formation. Using collagen gel overlays on MDCK cells as a model system, we observed phosphorylated myosin light chain (pMLC) at the leading edge of migrating lamellipodia. This epithelial remodeling led to the formation of multicellular branching epithelial tubular structures with extensive tight junctions. However, in cells expressing dominant-negative RhoN19, MLC phosphorylation, epithelial remodeling, and tubule formation were inhibited. Instead, only small apical lumens with a solitary tight junctional ring were observed, providing further evidence that Rho signaling through Rho-kinase is important in the regulation of epithelial tubule formation. Because the present model for the Rho signaling pathway proposes that Rac plays a prominent but reciprocal role in cell regulation, experiments were conducted using cells that expressed constitutively active RacV12. When incubated with collagen gels, RacV12-expressing cells formed small apical lumens with simple tight junctions, suggesting that Rac1 signaling also has a prominent role in the regulation of epithelial morphogenesis. Complementary collagen gel overlay experiments with wild-type MDCK cells demonstrated that endogenous Rac1 activation levels decreased over a time course consistent with lamellipodia and tubule formation. Under these conditions, Rac1 was initially localized to the basolateral membrane. However, after epithelial remodeling, activated Rac1 was observed primarily in lamellipodia. These studies support a model in which Rac1 and RhoA are important modulators of epithelial tubule formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338972     DOI: 10.1152/ajpcell.00287.2005

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  6 in total

1.  Pak1 regulates branching morphogenesis in 3D MDCK cell culture by a PIX and beta1-integrin-dependent mechanism.

Authors:  Michael P Hunter; Mirjam M Zegers
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-24       Impact factor: 4.249

Review 2.  Potential benefits of rho-kinase inhibition in arterial hypertension.

Authors:  Olaf Grisk
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

3.  PAR1b promotes cell-cell adhesion and inhibits dishevelled-mediated transformation of Madin-Darby canine kidney cells.

Authors:  Maya Elbert; David Cohen; Anne Müsch
Journal:  Mol Biol Cell       Date:  2006-05-17       Impact factor: 4.138

4.  Build them up and break them down: Tight junctions of cell lines expressing typical hepatocyte polarity with a varied repertoire of claudins.

Authors:  Brigitte Grosse; Jeril Degrouard; Danielle Jaillard; Doris Cassio
Journal:  Tissue Barriers       Date:  2013-06-04

5.  Next-generation sequencing of small RNAs from inner ear sensory epithelium identifies microRNAs and defines regulatory pathways.

Authors:  Anya Rudnicki; Ofer Isakov; Kathy Ushakov; Shaked Shivatzki; Inbal Weiss; Lilach M Friedman; Noam Shomron; Karen B Avraham
Journal:  BMC Genomics       Date:  2014-06-18       Impact factor: 3.969

6.  Epithelial sheet folding induces lumen formation by Madin-Darby canine kidney cells in a collagen gel.

Authors:  Sumire Ishida; Ryosuke Tanaka; Naoya Yamaguchi; Genki Ogata; Takeomi Mizutani; Kazushige Kawabata; Hisashi Haga
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.